1Research on the link between expedited review and drug reevaluation from the perspective of innovation incentive based on the European Union's experienceYAN Jian-zhou, ZHANG Li-yang, LEI Lu-qian, SHAO Rong2921-29252Research on quality risk identification and solutions of contract manufacturing under marketing authorization holder system:from the perspective of stakeholdersPAN Xiao-ying, MAO Ning-ying2926-29323The inspiration of Certificate of Supplementary Protection (CSP)System in Canada to new drug research and development in ChinaDONG Lai-di, GU Dong-lei, ZHU Lin, LUO Ma, XU Kuo, Ouyang Ning2933-29384Considerations on observation and measurement of efficacy variables in clinical trialsLIU Bing-lin, XUE Fei-ran2939-29475Study on regulation of CYP450 enzyme system to reduce liver toxicity through the compatibility of radix aconiti lateralis praeparata with Panax ginseng C.A.Mey and Glycyrrhiza uralensis FischLI Han, ZHANG Guang-ping, MA Meng, SU Ping, YANG Yi-fei, CHEN Teng-fei, YE Zu-guang2948-29536Progress of research and development of antibody-based therapeutics used for breast cancerWU Song-tao, ZHOU Shuang, XIE Ran, LUO Dao-huang, ZHAO Xia, ZHOU Ying, CUI Yi-min2954-29597The pharmacotherapy and research progress of drugs for Alzheimer's diseaseWANG Xiao-zhen, WANG Rong2960-29648Research progress in delivery of biological drugs by niosome-based drug delivery systemsWEI Xiao-qing, DAI Jing-ying, HE Lin2965-29689Working principle of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and its application in microbial researchFAN Xing-liang, CHEN Tian-you, LI Jing-yun, DUAN Kai2969-297310Bioequivalence study of ticagrelor under fasting and fed conditions in Chinese healthy volunteersXIE Qiu-fen, XU Jun-yu, WANG Jie, WANG Chun-yan, ZHAO Xia, CHEN Ji, HE Shi-ying, CUI Yi-min2974-298011Investigation on the quality of informed consent of subjects in clinical trials of anti-tumor drugsWU Min, LI Dan, LIU Xiao-hong2981-298612Design and practical experience of information management platform for investigator initiated trialsWU Qian, HU Jun, WANG Wen-hui2987-299113Interpretation of "Recommendations for Pharmacological Clinical Trials in Children with Functional Constipation" issued by the Rome Foundation Pediatric Subcommittee on Clinical TrialsWU Ge, HU Si-yuan, ZHANG Qi, CAI Qiu-han2992-299614Research on problems and countermeasures of the management of clinical trials' contracts in medical institutionsCAO Yu-ran, CAO Guo-ying, ZHANG Jing, WU Cui-yun, ZHAN Hui-zhong, MAO Ying2997-300015Exploring the road to GCP pharmacy construction and developmentWANG Jia-qing, XU Chun-min, WANG Wei-cong3001-300316Effect of puerarin on intestinal absorption of tanshinolLI Xing, CHEN Run-zhi, WU Jie-na, PANG Cai-xia, XU Ying, ZHAO Jie3004-300917Effect of Shenfu injection on autophagy of isolated cardiac myocyte after ischemia reperfusion in ratsWANG Yong, LIU Xue-wu, DAI Zhi, SHI Zhen-gang, ZENG Gui-rong3010-301518Construction of dual targeting anti-breast cancer fusion protein of De11-9-G129R-T3 eukaryotic expression vector and experimental study on anti-tumor activity in vitroGU Li, SU Yan, YAN Yan3016-302319Development of an HPLC-MS/MS method for determination of blinin in rat plasma and its pharmacokinetic studyWANG Ting, TONG Rong-sheng, ZOU Jing, JIN Yong-zhe3024-302920Effectiveness, safety and economy of pazopanib in advanced/metastatic renal cell carcinoma: a rapid health technology assessmentWANG Yan, WU Xiao-ling, MEN Peng, ZHOU Min-hua3030-3034 